Erin Lemovitz

Erin Lemovitz is a Toxicology Study Manager at Global Blood Therapeutics since May 2017, where responsibilities include coordinating non-GLP and GLP preclinical toxicology studies and managing study logistics with contract research organizations. Prior experience includes roles at Biogen as Biobank Project Manager, Associate Scientist III, and Stability Coordinator, contributing to blood sample processing, electronic inventory management, and laboratory support. Erin's career began at Genzyme as a Stability Specialist and included experience at Charles River Labs in various technician roles. Erin holds a Bachelor's degree in Chemistry and Natural Science from Worcester State College and has completed further education at the University of Tennessee-Health Science Center College of Medicine.